MAPT and Alzheimer disease: The findings from this study indicate that PART has a genetic architecture that partly overlaps with AD and other tauopathies and suggest a novel role for JADE1 (which interacts with 0N4R tau and is protective in vivo) as a modifier of neurofibrillary degeneration.